An immune world model with multi-agent orchestration for peptide vaccines
Abstract
Peptide-vaccine design requires a connection between vaccine-induced priming and recognition of the antigen naturally displayed by a tumor. We present an immune world model that preserves this connection through separate vaccine and tumor branches, endpoint-specific evidence and multi-agent orchestration. Native-recognition constraints held an altered peptide despite its higher presentation score, and targeted perturbations removed antigen-dependent benefit when required tumor-recognition conditions were absent. Public dendritic-cell data distinguished donor from antigen-source transfer: a context ranker achieved Recall@20 of 0.483 and 0.333 under the respective holdouts. Structure-informed receptor prediction added candidate-ranking evidence while preserving functional constraints and matched scenario trajectories. An assay observation model further concentrated a cross-presentation coefficient around its known value in a synthetic conditioning experiment. Together, these results establish a computational framework for linking molecular predictions, native-target requirements and conditional immune dynamics. The framework provides a reproducible basis for choosing peptide-vaccine candidates and the experiments needed to resolve their biological dependencies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prioritizing candidate peptides for cancer vaccines by PEPPRMINT: a statistical model to predict peptide presentation by HLA-I proteins
Laura Y. Zhou, Fei Zou, Wei Sun·bioRxiv·Sep 24, 2021
- Reengineering the antigen optimization process for superior neoantigen vaccine design
Guanqiao Zhang, Yaqi Fu, … Ruhong Zhou·bioRxiv·Aug 3, 2025
- Peptide-binding groove contraction linked to the lack of T-cell response: Using complex structure and energy to identify neoantigens
Y.-P. Pang, L. R. Elsbernd, … S. N. Markovic·bioRxiv·Apr 5, 2018
- Computer-aided prediction of antigen presenting cell modulators for designing peptide-based vaccine adjuvants
Gandharva Nagpal, Kumardeep Chaudhary, … Gajendra P. S. Raghava·Journal of Translational MedicinePeer-reviewed·Jul 3, 2018
- A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines
S. Feola, J. Chiaro, … V. Cerullo·eLifePeer-reviewed·Mar 22, 2022
- Mapping the Modification Landscape of MHC-I Epitopes: A Framework for Immunogenic Peptidomimetic Antigen Design
Sarah E. Newkirk, Joey J. Kelly, … Marcos M. Pires·bioRxiv·Mar 25, 2026